Holen Sie sich die Stockscreener-App
9.88
2.46%
-0.29
Schlusskurs vom Vortag:
$10.17
Offen:
$10.45
24-Stunden-Volumen:
65,221
Relative Volume:
0.49
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.32%
1M Leistung:
-20.26%
6M Leistung:
+33.15%
1J Leistung:
+49.17%
1-Tages-Spanne:
$9.76
$10.61
1-Wochen-Bereich:
$9.76
$11.96
52-Wochen-Spanne:
$3.62
$13.67
Direxion Daily Pharmaceutical Medical Bull 3 X Shares Stock (PILL) Company Profile
Firmenname
Direxion Daily Pharmaceutical Medical Bull 3 X Shares
Sektor
Branche
Telefon
-
Adresse
-
Compare PILL vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PILL
Direxion Daily Pharmaceutical Medical Bull 3 X Shares
|
9.88 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.92 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
663.97 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
666.89 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.86 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
594.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Pharmaceutical Medical Bull 3 X Shares Aktie (PILL) Neueste Nachrichten
Dermatomyositis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Octapharma, Argenx, AstraZeneca, Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharma, Holdings - Barchart.com
Dr. Ranjan Rajbanshi Scholarship for Medical Students Announces National Essay Competition for Aspiring Healthcare Professionals - Barchart.com
(PILL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Pharmaceutical Drug Delivery Market Projected to Reach $2,546.0 Billion by 2029 with Advancements in Targeted Therapies - Barchart.com
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years - Barchart.com
Paroxysmal Nocturnal Hemoglobinuria Market: Expanding Revenue Landscape to 2034 – DelveInsight | Alexion Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, AKARI Therapeutics, AstraZeneca - Barchart.com
Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Accelerates as 75+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com
RARE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
How (PILL) Movements Inform Risk Allocation Models - Stock Traders Daily
Hypertension Treatment Pipeline Shows Strong Momentum as 80+ Pharma Companies in the Race | DelveInsight - Barchart.com
Student-Led Nonprofit Empathy in Medicine Initiative Launches National Chapter for High School and College Students - Barchart.com
North America Biomarkers Market to Reach $42.25 Billion by 2030, Driven by Precision Medicine and Safety Biomarker Adoption - Barchart.com
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value - Barchart.com
XLRE Trails the S&P 500 by 5% Despite Lower Interest Rates That Were Supposed To Help - AOL.com
Trading Systems Reacting to (PILL) Volatility - Stock Traders Daily
6 Best Defense ETFs to Watch in 2026 - The Motley Fool
5 Small-cap Biotech ETFs to Watch - Investing News Network
How Direxion Daily Pharmaceutical & Medical Bull 3x Shares (PILL) Affects Rotational Strategy Timing - Stock Traders Daily
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Short Interest in Direxion Daily Pharmaceutical & Medical Bull 3X Shares (NYSEARCA:PILL) Drops By 37.4% - Defense World
ENN Energy (OTCMKTS:XNGSF) Trading Down 1.6% – Here’s Why - Defense World
(PILL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What You Need To Know Ahead of Baxter International's Earnings Release - Barchart.com
Is Apellis Pharmaceuticals’ FDA Win Just the Beginning? - AOL.com
Why Vera Therapeutics Stock Zoomed Higher Today - AOL.com
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
GE HealthCare’s Q4 2025 Earnings: What to Expect - Barchart.com
Responsive Playbooks and the PILL Inflection - Stock Traders Daily
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report - Barchart.com
Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Barchart.com
What Investors Should Know About a $163K AnaptysBio Insider Sale - AOL.com
Clarity Wealth Advisors LLC Reduces Holdings in iShares Global Healthcare ETF $IXJ - Defense World
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead - AOL.com
Understanding the Setup: (PILL) and Scalable Risk - Stock Traders Daily
U.S. Equity ETF Tracker | Storage price hikes spread, Micron hits new highs; 2x Long MU ETF rises over 7% - news.futunn.com
U.S. Stock ETF Tracker | Storage price hikes spread, Micron hits new highs, 2x Long MU ETF rises over 7% - 富途牛牛
Direxion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0327 - MSN
Why (PILL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Trump, nine pharmaceutical companies strike deal to cut prices - Yahoo! Finance Canada
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared - MSN
Top Performing Leveraged/Inverse ETFs: 12/14/2025 - ETF Database
CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks (CURE) - Seeking Alpha
Understanding Momentum Shifts in (PILL) - Stock Traders Daily
Form N-CSR UPRIGHT INVESTMENTS TRUS For: Sep 30 - StreetInsider
Improving Economic Signals Drives Participation In Direxion's Daily Retail Bull 3X Shares RETL ETF - inkl
Healthcare Relevancies Clashes With Premium Valuations For Direxion's LLY-Focused ELIL, ELIS ETFs - inkl
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - AOL.com
IonQ Wants to Bring Quantum Computing to Medicine. Should You Buy IONQ Stock Here? - Barchart.com
Avoiding Lag: Real-Time Signals in (PILL) Movement - news.stocktradersdaily.com
3 Highest-Yielding Dividend Kings To Buy, Hold, and Forget - Barchart.com
Finanzdaten der Direxion Daily Pharmaceutical Medical Bull 3 X Shares-Aktie (PILL)
Es liegen keine Finanzdaten für Direxion Daily Pharmaceutical Medical Bull 3 X Shares (PILL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):